Endotoxin binding and elimination by monocytes: Secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria

Infection and Immunity

Volumn 66, Issue 3, 1998, Pages 1135-1141

  Hiki, Naoki ^a   Berger, Dieter ^a   Prigl, Claus ^a   Boelke, Edwin ^a   Wiedeck, Heidemarie ^b   Seidelmann, Manuela ^a   Staib, Ludger ^a   Kaminishi, Michio ^a   Oohara, Takeshi ^a   Beger, Hans G ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; ENDOTOXIN; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MONOCYTE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; PROTEIN BINDING; SEPSIS;

EID: 0031888096     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.3.1135-1141.1998     Document Type: Article

References (56)

1. American College of Chest Physicians and Society of Critical Care Medicine Consensus Conference. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20: 864-874.
2. Baumgartner, J. D., T. X. O'Brien, T. N. Kirkland, M. P. Glauser, and E. J. Ziegler. 1987. Demonstration of cross-reactive antibodies to smooth gram-negative bacteria in antiserum to Escherichia coli J5. J. Infect. Dis. 156: 136-143. (Erratum, 156:1043.)
3. Bazil, V., and V. Horejsi. 1992. Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor ligand. J. Immunol. 1-49:747-753.
4. Bazil, V., V. Horejsi, M. Baudys, H. Kristofova, J. L. Strominger, W. Kostka, and I. Hilgert. 1986. Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur. J. Immunol. 16:1583-1589.
5. Berger, D., E. Bolke, H. Huegel, M. Seidelmann, A. Hannekum, and H. G. Beger. 1995. New aspects concerning the regulation of the post-operative acute phase reaction during cardiac surgery. Clin. Chim. Acta 239:121-130.
6. Berger, D., S. Schleich, M. Seidelmann, and H. G. Beger. 1991. Demonstration of an interaction between transferrin and lipopolysaccharide - an in vitro study. Eur. Surg. Res. 23:309-316.
7. Birkenmaier, C., Y. S. Hong, and J. K. Horn. 1992. Modulation of the endotoxin receptor (CD14) in septic patients. J. Trauma 32:473-478.
8. Burd, R. S., R. J. Battafarano, C. S. Cody, M. S. Farber, C. A. Ratz, and D. L. Dunn. 1993. Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two distinct mechanisms. Ann. Surg. 218:250-259.
9. Carey, F. J., A. I. Braude, and M. Zalesky. 1958. Studies with radioactive endotoxin. III. The effect of tolerance on the distribution of radioactivity after intravenous injection of Escherichia coli endotoxin labeled with CR51 1. J. Clin. Invest. 37:441-457.
10. Corrales, I., A. J. Weersink, J. Verhoef, and K. P. van Kessel. 1993. Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14. Immunology 80:84-89.
11. Duchow, J., A. Marchant, A. Crusiaux, C. Husson, C. Alonso Vega, D. De Groote, P. Neve, and M. Goldman. 1993. Impaired phagocyte responses to lipopolysaccharide in paroxysmal nocturnal hemoglobinuria. Infect. Immun. 61:4280-4285.
12. Duncan, R. L., Jr., and D. C. Morrison. 1984. The fate of E. coli lipopolysaccharide after the uptake of E. coli by murine macrophages in vitro. J. Immunol. 132:1416-1424.
13. Ertel, W., F. Krombach, J. P. Kremer, D. Jarrar, V. Thiele, J. Eymann, S. Muenzing, E. Faist, K. Messmer, and F. W. Schildberg. 1993. Mechanisms of cytokinc cascade activation in patients with sepsis: normal cytokine transcription despite reduced CD14 receptor expression. Surgery 114:243-250.
14. Fingerle, G., A. Pforte, B. Passlick, M. Blumenstein, M. Strobel, H. W. Ziegler Heitbrock. 1993. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 82:3170-3176.
15. Flegel, W. A., M. W. Baumstark, C. Weinstock, A. Berg, and H. Northoff. 1993. Prevention of endotoxin-induced monokine release by human low-and high-density lipoproteins and by apolipoprotein A-I. Infect. Immun. 61: 5140-5146.
16. Fox, E. S., P. Thomas, and S. A. Broitman. 1989. Clearance of gut-derived endotoxins by the liver. Release and modification of 3H, 14C-lipopolysaccharide by isolated rat Kupffer cells. Gastroenterology 96:456-461.
17. Freudenberg, M. A., N. Freudenberg, and C. Galanos. 1982. Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats. Br. J. Exp. Pathol. 63:56-65.
18. Freudenberg, M. A., B. Kleine, and C. Galanos. 1984. The fate of lipopolysaccharide in rats: evidence for chemical alteration in the molecule. Rev. Infect. Dis. 6:483-487.
19. Frey, E. A., D. S. Miller, T. G. Jahr, A. Sundan, V. Bazil, T. Espevik, B. B. Finlay, and S. D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665-1671.
20. Gallay, P., C. V. Jongeneel, C. Barras, M. Burnier, J. D. Baumgartner, M. P. Glauser, and D. Heumann. 1993. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes. J. Immunol. 150:5086-5093.
21. Gegner, J. A., R. J. Ulevitch, and P. S. Tobias. 1995. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J. Biol. Chem. 270:5320-5325.
22. Gessani, S., U. Testa, B. Varano, P. Di Marzio, P. Borghi, L. Conti, T. Barberi, E. Tritarelli, R. Martucci, D. Seripa, C. Peschle, and F. Belardelli. 1993. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors. J. Immunol. 151:3758-3766.
23. Golenbock, D. T., R. R. Bach, H. Lichenstein, T. S. Juan, A. Tadavarthy, and C. F. Moldow. 1995. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells. J. Lab. Clin. Med. 125:662-671.
24. Gray, P. W., G. Flaggs, S. R. Leong, R. J. Gumina, J. Weiss, C. E. Ooi, and P. Elsbach. 1989. Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. J. Biol. Chem. 264:9505-9509.
25. Grunwald, U., C. Kruger, and C. Schutt. 1993. Endotoxin-neutralizing capacity of soluble CD14 is a highly conserved specific function. Circ. Shock 39: 220-225.
26. Hailman, E., T. Vasselon, M. Kelley, L. A. Busse, M. C. Hu, H. S. Lichenstein, P. A. Detmers, and S. D. Wright. 1996. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J. Immunol. 156:4384-4390.
27. Hampton, R. Y., D. T. Golenbock, M. Penman, M. Krieger, and C. R. Raetz. 1991. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 352:342-344.
28. Haziot, A., G. W. Rong, V. Bazil, J. Silver, and S. M. Goyert. 1994. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. J. Immunol. 152:5868-5876.
29. Haziot, A., G. W. Rong, X. Y. Lin, J. Silver, and S. M. Goyert. 1995. Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). J. Immunol. 154:6529-6532.
30. Heinzelmann, M., M. Mercer Jones, W. G. Cheadle, and H. C. Polk. 1996. CD14 expression in injured patients correlates with outcome. Ann. Surg. 224:91-96.
31. Heumann, D., P. Gallay, C. Barras, P. Zaech, R. J. Ulevitch, P. S. Tobias, M. P. Glauser, and J. D. Baumgartner. 1992. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immunol. 148:3505-3512.
32. Heumann, D., P. Gallay, S. Betz Corradin, C. Barras, J. D. Baumgartner, and M. P. Glauser. 1993. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes. J. Infect. Dis. 167:1351-1357.
33. Kang, Y. H., R. S. Dwivedi, and C. H. Lee. 1990. Ultrastructural and immunocytochemical study of the uptake and distribution of bacterial lipopolysaccharide in human monocytes. J. Leukoc. Biol. 48:316-332.
34. Kang, Y. H., C. H. Lee, R. L. Monroy, R. S. Dwivedi, C. Odeyale, and H. H. Newball. 1992. Uptake, distribution and fate of bacterial lipopolysaccharides in monocytes and macrophages: an ultrastructural and functional correlation. Electron Microsc. Rev. 5:381-419.
35. Kirkland, T. N., F. Finley, D. Leturcq, A. Moriarty, J. D. Lee, R. J. Ulevitch, and P. S. Tobias. 1993. Analysis of lipopolysaccharide binding by CD14. J. Biol. Chem. 268:24818-24823.
36. Kitchens, R. L., R. J. Ulevitch, and R. S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176:485-494.
37. Kruger, C., C. Schutt, U. Obertacke, T. Joka, F. E. Muller, J. Knoller, M. Koller, W. Konig, and W. Schonfeld. 1991. Serum CD14 levels in polytraumatized and severely burned patients. Clin. Exp. Immunol. 85:297-301.
38. Landmann, R., A. M. Reber, S. Sansano, and W. Zimmerli. 1996. Function of soluble CD14 in serum from patients with septic shock. J. Infect. Dis. 173: 661-668.
39. Landmann, R., W. Zimmerli, S. Sansano, S. Link, A. Hahn, M. P. Glauser, and T. Calandra. 1995. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J. Infect. Dis. 171:639-644.
40. Levine, D. M., T. S. Parker, T. M. Donnelly, A. Walsh, and A. L. Rubin. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA 90:12040-12044.
41. Lin, R. Y., M. E. Astiz, J. C. Saxon, and E. C. Rackow. 1993. Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest 104:847-853.
42. Lin, R. Y., M. E. Astiz, J. C. Saxon, D. C. Saha, and E. C. Rackow. 1994. Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit. Care Med. 22:1595-1602. (Erratum, 23:1162, 1995).
43. Loppnow, H., F. Stelter, U. Schonbeck, C. Schluter, M. Ernst, C. Schutt, and H. D. Flad. 1995. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect. Immun. 63:1020-1026.
44. Luchi, M., and R. S. Munford. 1993. Binding, internalization, and deacylation of bacterial lipopolysaccharide by human neutrophils. J. Immunol. 151: 959-969.
45. McCall, C. E., L. M. Grosso Wilmoth, K. LaRue, R. N. Guzman, and S. L. Cousart. 1993. Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. J. Clin. Invest. 91:853-861.
46. Mimura, Y., S. Sakisaka, M. Harada, M. Sata, and K. Tanikawa. 1995. Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology 109:1969-1976.
47. Munford, R. S., and C. L. Hall. 1989. Purification of acyloxyacyl hydrolase, a leukocyte enzyme that removes secondary acyl chains from bacterial lipopolysaccharides. J. Biol. Chem. 264:15613-15619.
48. Peterson, A. A., and R. S. Munford. 1987. Dephosphorylation of the lipid A moiety of Escherichia coli lipopolysaccharide by mouse macrophages. Infect. Immun. 55:974-978.
49. Pollack, M., A. M. Espinoza, G. Guelde, N. L. Koles, L. M. Wahl, and C. A. Ohl. 1995. Lipopolysaccharide (LPS)-specific monoclonal antibodies regulate LPS uptake and LPS-induced tumor necrosis factor-alpha responses by human monocytes. J. Infect. Dis. 172:794-804.
50. Pugin, J., R. J. Ulevitch, and P. S. Tobias. 1993. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J. Exp. Med. 178: 2193-2200.
51. Schletter, J., H. Brade, L. Brade, C. Kruger, H. Loppnow, S. Kusumoto, E. T. Rietschel, H. D. Flad, and A. J. Ulmer. 1995. Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein. Infect. Immun. 63:2576-2580.
52. Tobias, P. S., K. Soldau, J. A. Gegner, D. Mintz, and R. J. Ulevitch. 1995. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270:10482-10488.
53. Wright, S. D., S. M. Levin, M. T. Jong, Z. Chad, and L. G. Kabbash. 1989. CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J. Exp. Med. 169: 175-183.
54. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433. (See comments.)
55. Wurfel, M. M., E. Hailman, and S. D. Wright. 1995. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J. Exp. Med. 181:1743-1754.
56. Yu, B., and S. D. Wright. 1996. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. J. Biol. Chem. 271: 4100-4105.